The period for which semaglutide remains stable and effective after the initial opening of its delivery device is a critical factor in ensuring patient safety and therapeutic benefit. This timeframe differs from the expiration date printed on the product packaging, which applies to unopened medication stored under specified conditions. Once the sterile barrier of a semaglutide pen or vial is compromised, environmental factors can impact the drug’s integrity.
Maintaining the potency and preventing contamination of semaglutide are paramount for optimal glycemic control and weight management. Deviations from recommended storage practices after opening can lead to reduced efficacy, potentially requiring increased dosages or alternative treatment strategies. Furthermore, improper handling increases the risk of bacterial growth, which could result in serious infections at the injection site.
